June 29, 2004

By: Whitney Walace
Website: http://www.1st-in-cosmetics.com

Facial topical products from specialty pharmaceutical manufacturer Fougera

Today, the specialty pharmaceutical manufacturer Fougera introduced Metronidazole Topical Cream, 0.75% . This product is AB rated to MetroCream by Galderma and is available in 45 g tubes. This important addition to a health care professional’s prescription choices will help meet the demand for a quality alternative to branded topicals.

David Klaum, Vice President of Sales & Marketing, notes that, With the introduction of Metronidazole Cream 0.75%, we have strengthened our broad range of quality facial topical products. This will help reduce health care costs across the board, while providing efficacy and safety without compromise.

As a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmic preparations, Fougera has received more topical generic FDA approvals than any other company during the past five years.

In fact, Fougera received four first approvals in 2003 alone. This ability to provide a continuing stream of new products benefits both health care providers seeking multi-source alternatives with the ability to reduce health care costs, and patients whose conditions warrant their application.

About The Author:

Whitney Walace is a successful author and regular contributor to http://www.1st-in-cosmetics.com.  Tips on skin care, hair care and beauty products to bring out natural beauty.